How GDPR and data sharing impact European cancer research

17/11/2022 | The Lancet

New research published in The Lancet examines the impact the EU General Data Protection Regulation (GDPR) has had on Europe's cancer research challenges. The paper (requires free subscription) outlines how "collaborative research is critical to ensure improvement in cancer care from early diagnosis to precise application of therapies. Data sharing ensures research robustness, adequate datasets for statistically significant results, economies of scales and cost-effective approaches through data reuse and enhancement, and ultimately expedites the validation and implementation of research findings."

In related news, EURACTIV reports the EU health data space proposal for sharing medical records data for research purposes will only work if there is a significant degree of trust from citizens. Fulvia Raffaelli, Head of the Digital Health unit at the European Commission's Directorate-General for Health and Food Safety said, "Health data is the blood running through the veins of our healthcare systems."

Read Full Story
Cancer, brain scan

What is this page?

You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.

The Privacy Newsfeed monitors over 300 global publications, of which more than 2,500 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.

Freevacy has been shortlisted in the Best Educator category.
The PICCASO Privacy Awards recognise the people making an outstanding contribution to this dynamic and fast-growing sector.